Citation Impact
Citing Papers
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
2012 StandoutScience
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Transcriptional regulation of macrophage polarization: enabling diversity with identity
2011 Standout
Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
2014 Standout
Gender medicine and oncology: report and consensus of an ESMO workshop
2019
Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial
2008
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
2011
Type I interferons in Sjögren's syndrome
2012
Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?
2014
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
2011
The Effect of Converting from Pravastatin to Simvastatin on the Pharmacodynamics of Warfarin
1999
Natural products: An evolving role in future drug discovery
2011 Standout
Oral Anticoagulant Therapy
2012 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Enhanced Oral Bioavailability of Paclitaxel Formulated in Vitamin E-TPGS Emulsified Nanoparticles of Biodegradable Polymers: In Vitro and In Vivo Studies
2010
Macrophages in immunoregulation and therapeutics
2023 Standout
The M1 and M2 paradigm of macrophage activation: time for reassessment
2014 Standout
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine
2011
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: Macrophage harbingers of disease severity
2011
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
2012
Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin
2015
Advances in understanding the pathogenesis of primary Sjögren's syndrome
2013
Primary Sjogren's syndrome: too dry and too tired
2010
TFOS DEWS II Epidemiology Report
2017 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
Empirical models for dosage optimization of four β-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin
2009
Type I interferons: crucial participants in disease amplification in autoimmunity
2010
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets
2010
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Regulation of type I interferon responses
2013 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
2010
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Analyzing nested experimental designs—A user-friendly resampling method to determine experimental significance
2022 StandoutNobel
Genetic predisposition to autoimmunity – What have we learned?
2011
Diagnosing Model Diagnostics
2007
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Pharmacogenetics of antimalarial drugs: effect on metabolism and transport
2009
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
2008
Macrophage Polarization
2016 Standout
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
2015 Standout
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
2015
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
Cytosolic DNA sensors regulating type I interferon induction
2011
Echinococcosis: Advances in the 21st Century
2019 Standout
Using Cluster Bootstrapping to Analyze Nested Data With a Few Clusters
2016
PEGylation Does Not Significantly Change the Initial Intravenous or Subcutaneous Pharmacokinetics or Lymphatic Exposure of Trastuzumab in Rats but Increases Plasma Clearance after Subcutaneous Administration
2015
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
2009
In VitroEfficacy of Dicationic Compounds and Mefloquine Enantiomers against Echinococcus multilocularis Metacestodes
2011
Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis
2012
Works of Emmanuelle Comets being referenced
Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2
2004
Association of an IRF5 gene functional polymorphism with Sjögren's syndrome
2007
STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling
2010
Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice
2004
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients*
1998
A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis
2007
Are Population Pharmacokinetic and/or Pharmacodynamic Models Adequately Evaluated?
2007
Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters
2007
Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors
2013
The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome
2009
Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide
2006
Population pharmacodynamic analysis of octreotide in acromegalic patients
2003
Population Pharmacokinetic-Pharmacogenetic Study of Nevirapine in HIV-Infected Cambodian Patients
2010
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed‐effects models
2013